Arginine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
901 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 6 | 6 | 6 | 7 | 17 | 40 |
| Healthy volunteers/patients | — | — | — | 11 | 2 | 1 | 4 | 23 | 39 |
| Diabetes insipidus | D003919 | — | E23.2 | 1 | 5 | 2 | 1 | 16 | 25 |
| Shock | D012769 | — | R57.1 | 1 | 7 | 6 | 7 | 7 | 24 |
| Syndrome | D013577 | — | — | 3 | 5 | 3 | 5 | 9 | 23 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 2 | 1 | 4 | 12 | 22 |
| Nocturia | D053158 | — | R35.1 | — | 7 | 10 | 2 | 4 | 22 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 5 | 2 | 1 | 1 | 13 | 21 |
| Nocturnal enuresis | D053206 | — | N39.44 | — | — | 3 | 9 | 9 | 21 |
| Enuresis | D004775 | — | R32 | — | — | 3 | 9 | 9 | 21 |
Show 117 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 2 | 7 | 2 | — | 23 | 32 |
| Neoplasms | D009369 | — | C80 | 15 | 5 | 2 | — | 5 | 23 |
| Carcinoma | D002277 | — | C80.0 | 7 | 5 | 2 | — | 4 | 16 |
| Dental caries | D003731 | EFO_0003819 | K02 | 1 | 3 | 2 | — | 10 | 16 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 3 | 5 | 5 | — | 1 | 12 |
| Wounds and injuries | D014947 | — | T14.8 | 2 | 3 | 1 | — | 7 | 12 |
| Neurogenic diabetes insipidus | D020790 | — | — | 1 | 3 | 1 | — | 6 | 11 |
| Fibrosis | D005355 | — | — | 2 | 2 | 1 | — | 6 | 10 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 2 | 1 | 1 | — | 6 | 9 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | 1 | — | 1 | — | 6 | 8 |
Show 65 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 5 | — | — | 3 | 9 |
| Colorectal neoplasms | D015179 | — | — | 1 | 3 | — | — | 6 | 9 |
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 3 | — | — | 2 | 8 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 4 | — | — | 1 | 8 |
| Melanoma | D008545 | — | — | 6 | 3 | — | — | — | 8 |
| Lymphoma | D008223 | — | C85.9 | 4 | 3 | — | — | 1 | 7 |
| Squamous cell carcinoma | D002294 | — | — | 4 | 1 | — | — | 2 | 6 |
| Leukemia | D007938 | — | C95 | 4 | 3 | — | — | 1 | 6 |
| Lung neoplasms | D008175 | — | C34.90 | 5 | 3 | — | — | — | 6 |
| Urinary bladder neoplasms | D001749 | — | C67 | 1 | 1 | — | — | 4 | 6 |
Show 115 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | 9 | 10 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | — | — | — | 6 | 7 |
| Obstructive lung diseases | D008173 | — | — | 1 | — | — | — | 5 | 6 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 3 | — | — | — | 2 | 5 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | 2 | — | — | — | 3 | 5 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | — | — | — | 3 | 4 |
| Heart disease risk factors | D000082742 | — | — | 4 | — | — | — | — | 4 |
| Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | 2 | 3 |
| Vasoconstriction | D014661 | — | — | 3 | — | — | — | — | 3 |
Show 45 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 8 | 8 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 7 | 7 |
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 6 | 6 |
| Diet therapy | D004035 | — | — | — | — | — | — | 4 | 4 |
| Communicable diseases | D003141 | — | — | — | — | — | — | 4 | 4 |
| Postoperative complications | D011183 | — | — | — | — | — | — | 4 | 4 |
| Burns | D002056 | — | T30.0 | — | — | — | — | 4 | 4 |
| Polydipsia | D059606 | — | R63.1 | — | — | — | — | 4 | 4 |
| Musculoskeletal diseases | D009140 | — | — | — | — | — | — | 3 | 3 |
| Musculoskeletal pain | D059352 | — | — | — | — | — | — | 3 | 3 |
Show 247 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
+
Arginine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
132,321 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use